ALLURION TECHNOLOGIES INC (ALUR) Stock News

USA - NYSE:ALUR - US02008G2012 - Common Stock

1.39 USD

-0.01 (-0.71%)

Last: 11/18/2025, 12:50:21 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ALUR Latest News, Press Relases and Analysis

All

Press Releases

5 hours ago - By: Allurion Technologies, Inc.

Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss

10 hours ago - By: Zacks Investment Research - Mentions: BSX BLFS PODD

Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion

a day ago - By: Zacks Investment Research - Mentions: BSX BLFS PODD

4 Medical Product Stocks to Watch From a Challenging Industry

6 days ago - By: Allurion Technologies, Inc.

Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update

7 days ago - By: Benzinga

A Look at Allurion Technologies's Upcoming Earnings Report

3 months ago - By: Benzinga

Preview: Allurion Technologies's Earnings

7 days ago - By: Allurion Technologies, Inc.

Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing

12 days ago - By: Allurion Technologies, Inc.

Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025

a month ago - By: Allurion Technologies, Inc.

Allurion Announces Landmark Peer-Reviewed Publication on Consecutive Use of the Allurion Smart Capsule Showing More Than 20% Weight Loss

2 months ago - By: Allurion Technologies, Inc.

Allurion to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

3 months ago - By: Zacks Investment Research - Mentions: A

Allurion Technologies, Inc. (ALUR) Reports Q2 Loss, Misses Revenue Estimates

3 months ago - By: The Motley Fool

Allurion Revenue Drops 71 Percent in Q2

3 months ago - By: Allurion Technologies, Inc.

Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update

3 months ago - By: Zacks Investment Research - Mentions: BLFS

BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2

3 months ago - By: Allurion Technologies, Inc.

Allurion to Report Second Quarter 2025 Financial Results on August 13, 2025

4 months ago - By: Allurion Technologies, Inc.

Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry

4 months ago - By: Zacks Investment Research - Mentions: ZYXI

Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates

4 months ago - By: Allurion Technologies, Inc.

Allurion Announces New Publications on Long-Term Weight Loss Results with the Allurion Program

4 months ago - By: Allurion Technologies, Inc.

Allurion Announces Strategic Distribution Partnership with Minogue Medical in Canada to Pioneer New Approach Focused on Metabolically Healthy Weight Loss

4 months ago - By: Allurion Technologies, Inc.

Allurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints

5 months ago - By: Allurion Technologies, Inc.

Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS

6 months ago - By: Allurion Technologies, Inc.

Allurion to Present at Jefferies Global Healthcare Conference

6 months ago - By: Yahoo Finance - Mentions: WFC JPM MEC PSTG ...

Mayville Engineering Company, Inc. (MEC) Seals $140M Accu-Fab Acquisition Deal

6 months ago - By: Yahoo Finance - Mentions: RCKT NRXP USB PSTG ...

Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death

6 months ago - By: Yahoo Finance - Mentions: BIIB MAIA HOLX DUOL ...

Allurion Technologies Inc. (ALUR) Returns to France with 12.2% Weight Loss, 6.6% Muscle Gain Results

6 months ago - By: Yahoo Finance - Mentions: GM MEC NWG BCS

General Motors Company (GM) to Invest $888 Million in Tonawanda Propulsion Plant

6 months ago - By: Allurion Technologies, Inc.

Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program